Sami Bercin

Sami Bercin

Auto-generated profile, based on publicly available information

Sami Bercin

Department of Otorhinolaryngology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkiye

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
SBSami Berçin
Sami Berçin
AKAhmet Kutluhan
Ahmet Kutluhan
KBKazim Bozdemir
Kazim Bozdemir
GYGökhan Yalçiner
Gökhan Yalçiner
NSNeslihan Sari
Neslihan Sari
ÖKÖzgür Karameşe
Özgür Karameşe
Successful canal wall down (CWD) mastoidectomy requires removal of all diseased air cells, lowering of the facial ridge to the mastoid segment of the facial nerve, complete removal of the lateral epitympanic wall, and amputation of the mastoid tip. Additionally, the inferior canal wall should be lowered to adequately expose the hypotympanum, which allows a smooth transition into the mastoid cavity. An adequate meatoplasty is also necessary. Closed supratubal recess should be opened, anulus and tympanic membrane remnant should be removed in CWD cases. Revision mastoidectomy has a high success rate in obtaining a dry and epithelialized ear. This study reports revision mastoidectomy results and indicates factors that must receive attention in chronic otitis media surgery to produce less revision surgery. Thirty-five patients who underwent revision mastoidectomy with or without cholesteatoma between 2005 and 2008 were analyzed retrospectively. Patients who had revision mastoidectomy with previous intact canal wall (ICW) or CWD mastoidectomies were included in the study. Patients were aged 32-69 years (mean 57.4). There were 22 female and 13 male patients. Revision mastoidectomies were applied to 14 previous ICW and 21 prior CWD mastoidectomies. Of the 35 patients, 24 patients had cholesteatoma and 11 of them did not. Of the patients who had revision surgery, 10 had ICW mastoidectomy and 25 had CWD mastoidectomy. After revision mastoidectomy, at 3-25 months follow-up (mean 16.7 months), 29 patients had been successfully treated; they had dry well epithelialized cavity, with no findings of persistent, recurrent discharge or granulation tissue and cholesteatoma. In 21 patients in whom revision CWD mastoidectomy was performed, causes of failure of previous ear surgery in order of frequency were recurrent or persistent cholesteatoma and narrow meatoplasty (80.9%), persistent sinodural angle air cells and close supratubal recess (71.4%), high facial ridge and inadequate canalplasty (66.7%), persistent tegmental air cells and tympanic membrane remnant (57.1%), persistent mastoid apex air cells and open eustachian orifice (52.4%). Causes of failure after our revision ICW mastoidectomy in order of frequency were persistent or recurrent cholesteatoma (78.6%), closed supratubal recess (64.3%), persistent sinodural angle air cells, inadequate canalplasty and persistent mastoid apex air cells (57.1%), persistent tegmental air cells (42.9%).

21 May 2008 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
SBSami Bercin
Sami Bercin
AKAhmet Kutluhan
Ahmet Kutluhan
VYVeysel Yurttas
Veysel Yurttas
GYGokhan Yalcıner
Gokhan Yalcıner
KBKazım Bozdemir
Kazım Bozdemir
NSNeslihan Sarı
Neslihan Sarı

1 May 2011 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
SBSami Bercin
Sami Bercin
TMTogay Muderris
Togay Muderris
MKMuzaffer Kiris
Muzaffer Kiris
AKAlper Kanmaz
Alper Kanmaz
OKOlcay Kandemir
Olcay Kandemir
Sinonasal fibrosarcoma is an infrequently occurring malignant neoplasm. It usually presents with nasal obstruction and epistaxis, as do other sarcomas in this region. The final diagnosis is based on the histopathologic and immunohistochemical examination. We report a case involving a 47-year-old woman with a 2-year history of left nasal obstruction and proptosis, as well as diplopia for the 2 months preceding her visit. Computed tomography and magnetic resonance imaging showed a neoplasm occupying the left nasal cavity, ethmoid sinuses, and bilateral frontal sinuses. The neoplasm also was eroding the medial wall of the maxillary sinus, the lamina papyracea, the cribriform plate, and the anterior wall of the frontal sinus. Complete removal of the tumor was achieved both endoscopically and through a Lynch incision. Sinonasal fibrosarcoma was found on histopathologic examination.

12 February 2021 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
BABengi Arslan
Bengi Arslan
SBSami Bercin
Sami Bercin
SASibel Aydogan
Sibel Aydogan
YIYuce Islamoglu
Yuce Islamoglu
BDBedia Dinc
Bedia Dinc

1 November 2013 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
TMTogay Muderris
Togay Muderris
SBSami Bercin
Sami Bercin
ESErgun Sevil
Ergun Sevil
BABaran Acar
Baran Acar
MKMuzaffer Kiris
Muzaffer Kiris
In recent years, transoral robotic surgery has been introduced as an efficient and a reliable method for excision of selected oral cavity, tongue base, and supraglottic tumors in otolaryngology. In this case report, a 39-year-old woman with a history of hoarseness and dysphagia for approximately 6 months is presented. The patient was diagnosed with atypical carcinoid tumor on the laryngeal aspect of the epiglottis, and excision of the tumor was performed through transoral robotic surgery using the robotic da Vinci surgical system, a 0-degree three-dimensional endoscope, 5-mm microinstruments compatible with the da Vinci robot, and a Feyh-Kastenbauer/Weinstein-O'Malley retractor. The mass was removed completely, and no complications occurred. The patient recovered without a need for tracheotomy. Findings of the 1-year clinical follow-up revealed no locoregional recurrence or distant metastasis. This case shows, once again, that transoral robotic surgery could be used safely and effectively regardless of pathologic diagnosis in the supraglottic region tumors.

1 January 2009 in Indian Journal of Dermatology
Verified
Journal Article
Open access
PDF file
SBSami Bercin
Sami Bercin
AKAhmet Kutluhan
Ahmet Kutluhan
AMAhmet Metin
Ahmet Metin
DSDinc Suren
Dinc Suren
Malignant eccrine spiradenomas are exceedingly rare tumors. They can arise from a preexisting eccrine spiradenoma or occur as a primary malignant tumor. Clinical features of these tumors may include a history of enlargement in a previously stable lesion. Tumor can be of low or high grade. Low-grade malignant eccrine spiradenoma has a better prognosis. We present a malignant eccrine spiradenoma arising from a preexisting eccrine spiradenoma, which has an infrequent localization between lateral edge of nose and medial canthus.